ApTOLL

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameApTOLL
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 4 antagonists
TargetsToll like receptor 4
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFranceSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesaptaTargets SL
China Registration ClassN/A

Develop Information

Active CompaniesMerck KGaA, Darmstadt, GermanyaptaTargets SL
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A